Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypoglycemic Agents”

211 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 211 results

Not applicableStudy completedNCT00254124
What this trial is testing

Use of a Portion Control Food Tool to Induce Weight Loss in Obese Type 2 Diabetics.

Who this might be right for
Type 2 Diabetes MellitusObesity
University of Calgary 130
Not applicableStudy completedNCT04430660
What this trial is testing

Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Complications in Diabetic Patients

Who this might be right for
DiabetesHypoglycemia
Pennington Biomedical Research Center 8
Large-scale testing (Phase 3)Ended earlyNCT02864953
What this trial is testing

Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction

Who this might be right for
Brain EdemaStroke, Acute
Remedy Pharmaceuticals, Inc. 535
Large-scale testing (Phase 3)Study completedNCT04841096
What this trial is testing

Oral Combination of Glimepiride/Vildagliptin/Metformin in Patients With T2D and Dual Treatment Failure

Who this might be right for
Type 2 Diabetes
Laboratorios Silanes S.A. de C.V. 162
Not applicableStudy completedNCT00315939
What this trial is testing

Improving Control and Reducing the Risk of Hypoglycemic Episodes in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Boris Kovatchev, PhD 120
Early research (Phase 1)Study completedNCT00422357
What this trial is testing

Effect of Urtica Dioica on Glycemic Control in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Shahid Beheshti University of Medical Sciences 56
Large-scale testing (Phase 3)Study completedNCT00688701
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 361
Large-scale testing (Phase 3)Study completedNCT00658021
What this trial is testing

Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
AstraZeneca 122
Not applicableStudy completedNCT00884611
What this trial is testing

Development of Algorithms for a Hypoglycemic Prevention Alarm: Closed Loop Study

Who this might be right for
Type 1 Diabetes Mellitus
Stanford University 20
Not applicableWithdrawnNCT03577184
What this trial is testing

Evaluating the Glycemic Control wIth Vildagliptin and Metformin Combination Therapy.

Who this might be right for
Diabetes Mellitus, Type 2
Clinision
Post-approval studies (Phase 4)Study completedNCT00970528
What this trial is testing

Glucose Reduction by Early Acarbose Treatment in Basal Insulin

Who this might be right for
Diabetes Mellitus, Type 2
Bayer 124
Not applicableStudy completedNCT01359904
What this trial is testing

Effect of Dialysis Glucose Bath on Glycemic Control in Hemodialysis (HD)

Who this might be right for
Diabetes Type 2
McGill University Health Centre/Research Institute of the McGill University Health Centre 33
Large-scale testing (Phase 3)Study completedNCT01616784
What this trial is testing

The REPOSE (Relative Effectiveness of Pumps Over MDI and Structured Education) Trial

Who this might be right for
Type 1 Diabetes
Sheffield Teaching Hospitals NHS Foundation Trust 267
Early research (Phase 1)Study completedNCT04907006
What this trial is testing

A Food-drug Interaction Study of SY-004 in Healthy Subjects

Who this might be right for
Type 2 Diabetes
Suzhou Yabao Pharmaceutical R&D Co., Ltd. 24
Not applicableUnknownNCT05272839
What this trial is testing

Association Between Natural Hypoglycemic Foods and Blood Sugar Level: A Pilot Study

Who this might be right for
Type II Diabetes
Antenna Foundation 124
Post-approval studies (Phase 4)Ended earlyNCT01799057
What this trial is testing

The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication

Who this might be right for
Peripheral Arterial DiseaseIntermittent Claudication
Baker Heart and Diabetes Institute 2
Testing effectiveness (Phase 2)Study completedNCT00631007
What this trial is testing

A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator

Who this might be right for
Type 2 Diabetes Mellitus
InteKrin Therapeutics, Inc. 367
Large-scale testing (Phase 3)UnknownNCT05641337
What this trial is testing

Research on Optimal Strategy of Hypoglycemic Therapy for Cirrhosis With Diabetes

Who this might be right for
Liver CirrhosisDiabetes
Huashan Hospital 184
Large-scale testing (Phase 3)Study completedNCT00290927
What this trial is testing

Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 390
Post-approval studies (Phase 4)Study completedNCT00994682
What this trial is testing

University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)

Who this might be right for
Nonalcoholic SteatohepatitisNonalcoholic Fatty Liver DiseaseType 2 Diabetes Mellitus
University of Florida 176
Load More Results